<DOC>
	<DOCNO>NCT00218023</DOCNO>
	<brief_summary>Cocaine dependence major public health problem ; effective primary treatment cocaine dependent individual yet find . The purpose study identify subpopulation baseline condition responsive treatment cocaine dependent individual .</brief_summary>
	<brief_title>Medications Stopping Cocaine Dependence Preventing Relapse</brief_title>
	<detailed_description>Cocaine strong central nervous system stimulant widely abuse throughout United Sates . Due widespread use , important develop effective treatment cocaine dependence . Motivational Interviewing ( MI ) often effective combine drug treatment . Baseline condition ( e.g. , abstinence status ) population type ( e.g. , ethnicity gender ) often affect individual responds treatment drug dependence . The purpose study determine influence baseline status population type treatment response cocaine dependent individual . In addition , study examine various cocaine abuse medication target different neuronal system , withdrawal symptom , relapse drug use . This study take place two phase . Phase I last 4 week ; participant receive MI undergo contingency-based urine test order achieve desire baseline condition . Phase II last 12 week . Participants Phase II randomly assign receive one four treatment : 1 ) 50 mg naltrexone , 2 ) 800/200 mg levodopa/carbidopa , 3 ) 400 mg modafinil , 4 ) placebo . During Phase II , participant receive psychotherapy contingency management . Participants complete urine drug screening test 3 time week . Follow-up study visit occur 3 6 month follow Week 12 , include objective self-reported drug use .</detailed_description>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Carbidopa</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>Meets DSMIV criterion current cocaine dependence Meet diagnostic criterion serious psychiatric symptom and/or disorder would interfere participation treatment study ( e.g. , psychosis ; mania ; suicidal/ homicidal ideation ) include form drug dependence , nicotine cannabis except . Medical condition contraindicate naltrexone therapy ( e.g. , past history opioid use 30 day prior study entry significant hepatocellular injury ) Medical condition contraindicate modafinil therapy ( e.g. , hypertension , seizure , arrhythmia , coronary artery disease ) Medical condition contraindicate levodopa/carbidopa therapy ( e.g. , severe pulmonary/cardiovascular disease , narrow angle glaucoma , melanoma , history peptic ulcer , renal function impairment ) Requires certain medication Current recent treatment substance use psychiatric condition On parole probation require report drug use officer court Pending incarceration Pregnant breastfeeding Unable read , write , speak English Plans leave study area within 3 month study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>cocaine</keyword>
	<keyword>cocaine addiction</keyword>
	<keyword>cocaine abuse</keyword>
	<keyword>relapse prevention</keyword>
</DOC>